Merck KGaA, Darmstadt, Germany Completes Millipore Acquisition and Launches New EMD Millipore Division (Merck Millipore Division outside U.S. and Canada)

Merck KGaA*, a global pharmaceutical and chemical company, today announced the successful completion of its acquisition of Millipore Corporation (formerly NYSE: MIL), a leading Life Science company based in Billerica, Massachusetts, USA, for an aggregate purchase price including debt and cash of approximately $7.0 billion. Merck agreed to acquire Millipore on February 28, 2010 for $107 in cash per share of Millipore common stock.

Source: Millipore